HIV is a virus that causes AIDS by compromising the immune system. It is transmitted through certain bodily fluids and can be contracted through unprotected sex, needle sharing, or from mother to child. There are stages of HIV infection from initial infection to full blown AIDS. While there is no cure for HIV/AIDS, treatment involves antiviral drugs to suppress the virus and prevent opportunistic infections. Prevention methods promote abstinence, monogamy, condom use, clean needles, and preventing mother to child transmission.
Lab diagnosis of HIV infection/certified fixed orthodontic courses by Indian ...Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.for more details please visit
www.indiandentalacademy.com
Lab diagnosis of HIV infection/certified fixed orthodontic courses by Indian ...Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.for more details please visit
www.indiandentalacademy.com
HIV AIDS is one of the most dreadful of all diseases. Newer drugs and drug combination are coming quite frequently. Attempts to design an HIV vaccine is also underway.
This seminar is my attempt this interesting topic with all the latest data I could collect on the internet.
Provides information on diagnosis and management of acute HIV, including clinical recommendations and key points regarding presentation, diagnosis, and management, including while on pre- or post-exposure prophylaxis (PrEP or PEP).
Find more information at https://www.hivguidelines.org/hiv-testing-acute-infection/acute-hiv/
Sponsored by the New York State Department of Health (NYSDOH) AIDS Institute (AI) and the HIV Clinical Guidelines Program
HIV AIDS is one of the most dreadful of all diseases. Newer drugs and drug combination are coming quite frequently. Attempts to design an HIV vaccine is also underway.
This seminar is my attempt this interesting topic with all the latest data I could collect on the internet.
Provides information on diagnosis and management of acute HIV, including clinical recommendations and key points regarding presentation, diagnosis, and management, including while on pre- or post-exposure prophylaxis (PrEP or PEP).
Find more information at https://www.hivguidelines.org/hiv-testing-acute-infection/acute-hiv/
Sponsored by the New York State Department of Health (NYSDOH) AIDS Institute (AI) and the HIV Clinical Guidelines Program
What is HIV? How an HIV infections advances to AIDS? What is AIDS? What are the medicine to stop HIV replication? What are the diagnostic tests? What are the medical managements for AIDS? What are the categories of HIV infection? Symptoms of HIV infection? What should be the nurse care plan for an AIDS patient? How can people prevent HIV infection? All these questions are answered in this presentation.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Aids
1. ACQUIRED IMMUNE DEFICIENCYACQUIRED IMMUNE DEFICIENCY
SYNDROMESYNDROME
(AIDS)(AIDS)
114JWC08864
JAMSHEDPUR WOMEN’S COLLEGE
Presentation on
PRESENTED BY:
NAME-Kalyani Mishra
REGD-14JWC08864
BRANCH-Biotechnology
2. CONTENTCONTENT
• What are HIV & AIDSWhat are HIV & AIDS
• EtiologyEtiology
• What does HIV look likeWhat does HIV look like
• Stages of HIVStages of HIV
• Two key factor of immune systemTwo key factor of immune system
• HIV transmissionHIV transmission
• Testing options for HIVTesting options for HIV
• TreatmentTreatment
• PreventionPrevention
• ConclusionConclusion
14JWC08864 2
3. WHAT ARE HIV & AIDSWHAT ARE HIV & AIDS
• HIV- (Human Immunodeficiency Virus) The virusHIV- (Human Immunodeficiency Virus) The virus
compromises the body’s ability to handle disease andcompromises the body’s ability to handle disease and
causes AIDS.causes AIDS.
• AIDS is the final stage of HIV infection. When theAIDS is the final stage of HIV infection. When the
immune system CD4 cells drop to a very low level, aimmune system CD4 cells drop to a very low level, a
person's ability to fight infection is lost.person's ability to fight infection is lost.
314JWC08864
4. ETIOLOGYETIOLOGY
• The world first became aware of AIDS in the earlyThe world first became aware of AIDS in the early
1980’s.1980’s.
• Researchers aren’t sure exactly when and how HIVResearchers aren’t sure exactly when and how HIV
developed.developed.
• The most likely theories assume that HIV-1wasThe most likely theories assume that HIV-1was
transmitted to humans from chimpanzees sometime intransmitted to humans from chimpanzees sometime in
the early 20th century.the early 20th century.
414JWC08864
5. WHAT DOES HIV LOOK LIKEWHAT DOES HIV LOOK LIKE??
514JWC08864
6. STAGES OF HIV :STAGES OF HIV :
STAGE 1- PRIMARYSTAGE 1- PRIMARY
• Short, flu-like illness - occurs one to six weeks afterShort, flu-like illness - occurs one to six weeks after
infectioninfection
• No symptoms at allNo symptoms at all
• Infected person can infect other peopleInfected person can infect other people
614JWC08864
7. STAGE 2 - ASYMPTOMATICSTAGE 2 - ASYMPTOMATIC
• Lasts for an average of ten yearsLasts for an average of ten years
• This stage is free from symptomsThis stage is free from symptoms
• There may be swollen glandsThere may be swollen glands
• The level of HIV in the blood drops to very low levelsThe level of HIV in the blood drops to very low levels
• HIV antibodies are detectable in the bloodHIV antibodies are detectable in the blood
714JWC08864
8. STAGE 3 - SYMPTOMATICSTAGE 3 - SYMPTOMATIC
• The symptoms are mildThe symptoms are mild
• The immune system deterioratesThe immune system deteriorates
• Emergence of opportunistic infections and cancersEmergence of opportunistic infections and cancers
814JWC08864
9. STAGE 4 - HIV AIDSSTAGE 4 - HIV AIDS
• The immune systemThe immune system
weakensweakens
• The illnesses become moreThe illnesses become more
severe leading to an AIDSsevere leading to an AIDS
diagnosisdiagnosis
914JWC08864
10. TWO KEY FACTOR OF IMMUNE SYSTEMTWO KEY FACTOR OF IMMUNE SYSTEM
T4 or CD4 cell Antibodies
HIV
1014JWC08864
11. HOW DOES HIV GET INTO A T-CELLHOW DOES HIV GET INTO A T-CELL
1. HIV attaches to1. HIV attaches to
infection fighting T4 cellinfection fighting T4 cell
2. Locks on to two2. Locks on to two
entry areas of the T4entry areas of the T4
cell at once.cell at once.
(Keys in lock)(Keys in lock)
3. Tricks T4 cell to3. Tricks T4 cell to
allow Virus RNA to enterallow Virus RNA to enter
1114JWC08864
12. WHAT DOES HIV DO INSIDE A T-CELLWHAT DOES HIV DO INSIDE A T-CELL ??
1. Virus’s RNA changes into1. Virus’s RNA changes into
DNADNA
2. Enters Cell nucleus &2. Enters Cell nucleus &
becomes part of Host’s DNA!becomes part of Host’s DNA!
3. Programs T cell to produce3. Programs T cell to produce
virus in abundancevirus in abundance
4. New viruses bud off Host T4. New viruses bud off Host T
cell, killing T cell, & enterscell, killing T cell, & enters
bloodstreambloodstream
5. New HIV viruses infect5. New HIV viruses infect
more T cellsmore T cells
1214JWC08864
14. INFECTED BODY FLUIDINFECTED BODY FLUID
Four Fluids, if infected, can transmit HIVFour Fluids, if infected, can transmit HIV
• BloodBlood
• SemenSemen
• Vaginal SecretionsVaginal Secretions
• Breast MilkBreast Milk
If these enter the bodyIf these enter the body
1414JWC08864
15. THREE MOST FREQUENT WAY TO GETTHREE MOST FREQUENT WAY TO GET
INFECTEDINFECTED
Three Most frequent ways to get infectedThree Most frequent ways to get infected
1. Unprotected sexual intercourse1. Unprotected sexual intercourse
2. Injected Drug Use2. Injected Drug Use
3. From an infected mother to her infant3. From an infected mother to her infant..
Other, much more rare, ways to get infectedOther, much more rare, ways to get infected
a. Blood Transfusions / Organ Transplanta. Blood Transfusions / Organ Transplant
1514JWC08864
16. TESTING OPTION FOR HIV :TESTING OPTION FOR HIV :
ANONYMOUS TESTINGANONYMOUS TESTING
• No name is usedNo name is used
• Unique identifying numberUnique identifying number
• Results issued only to test recipientResults issued only to test recipient
1614JWC08864
17. TESTING OPTION FOR HIV :TESTING OPTION FOR HIV :
CONFIDENTIAL TESTINGCONFIDENTIAL TESTING
• Person’s name is recorded along with HIV resultsPerson’s name is recorded along with HIV results
• Name and positive results are reported to the StateName and positive results are reported to the State
Department and the Centers for Disease Control andDepartment and the Centers for Disease Control and
PreventionPrevention
• Results issued only to test recipientResults issued only to test recipient
1714JWC08864
19. BLOOD DETECTION TESTSBLOOD DETECTION TESTS
• Enzyme-Linked Immunosorbent Assay/EnzymeEnzyme-Linked Immunosorbent Assay/Enzyme
Immunoassay (ELISA/EIA)Immunoassay (ELISA/EIA)
• Polymerase Chain Reaction (PCR)Polymerase Chain Reaction (PCR)
• Western Blot Confirmatory testWestern Blot Confirmatory test
1914JWC08864
20. URINE TESTINGURINE TESTING
Urine Western BlotUrine Western Blot
•As sensitive as testing bloodAs sensitive as testing blood
•Safe way to screen for HIVSafe way to screen for HIV
•Can cause false positives in certainCan cause false positives in certain
people at high risk for HIVpeople at high risk for HIV
2014JWC08864
21. ORAL TESTINGORAL TESTING
OrasureOrasure
•The only FDA approved HIV antibody.The only FDA approved HIV antibody.
•As accurate as blood testingAs accurate as blood testing
•Draws blood-derived fluids from theDraws blood-derived fluids from the
gum tissue.gum tissue.
•NOT A SALIVA TEST!NOT A SALIVA TEST!
2114JWC08864
23. TREATMENTS :TREATMENTS :
OPPORTUNISTIC INFECTION TREATMENTOPPORTUNISTIC INFECTION TREATMENT
• Issued in an event where antiretroviral drugs are not availableIssued in an event where antiretroviral drugs are not available
• Influenza vaccination and pneumococcal polysaccharide vaccineInfluenza vaccination and pneumococcal polysaccharide vaccine
are often recommended in people with HIV/AIDS with someare often recommended in people with HIV/AIDS with some
evidence of benefit.evidence of benefit.
2314JWC08864
25. CONCLUSIONCONCLUSION
• AIDS is a disease caused by the HIV infection, which is basically a weakeningAIDS is a disease caused by the HIV infection, which is basically a weakening
of one’s immune system.of one’s immune system.
• It can only be spread through blood transfusions, sexual contact and from anIt can only be spread through blood transfusions, sexual contact and from an
infected mother to her unborn child.infected mother to her unborn child.
• HIV/AIDS has had a great impact on society, both as an illness and as aHIV/AIDS has had a great impact on society, both as an illness and as a
source of discrimination.source of discrimination.
• Awareness campaigns should be conducted for the greater well-being andAwareness campaigns should be conducted for the greater well-being and
welfare of the HIV/AIDS patients.welfare of the HIV/AIDS patients.
14JWC08864 25
26. REFERENCEREFERENCE
• Microbiology by Pani KarMicrobiology by Pani Kar
• https://en.wikipedia.org/wiki/HIV/AIDShttps://en.wikipedia.org/wiki/HIV/AIDS
• https://www.slideshare.comhttps://www.slideshare.com
• https://www.avert.org/about-hiv-aids/what-hiv-aidshttps://www.avert.org/about-hiv-aids/what-hiv-aids
• Images from: images.google.co.inImages from: images.google.co.in
14JWC08864 26